New potential therapeutic goals: subchondral bone and progression of osteoarthritis.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D015519:Bone Density / Q000502:physiology; D002118:Calcium / Q000378:metabolism; D015444:Exercise; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use; D010003:Osteoarthritis / Q000235:genetics / Q000517:prevention & control / Q000628:therapy*; D010024:Osteoporosis / Q000188:drug therapy / Q000503:physiopathology; D018167:Receptors, Calcitriol / Q000235:genetics